|
"liang ph"的相關文件
顯示項目 1-10 / 29 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-08 |
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studies
|
Tang, WF;Tsai, HP;Chin, YF;Tsai, SK;Lin, CC;Ngo, ST;Liang, PH;Jheng, JR;Hsieh, CF;Lee, JC;Chang, YH;Chang, TY;Lin, CY;Lin, GH;Cai, JY;Chen, YL;Chen, YS;Liu, PC;Yang, CM;Shadbahr, T;Tang, J;Wang, LY;Chen, CC;Hsu, SC;Lee, HY;Wang, WC;Thai, QM;Pham, MQ;Horng, JT |
| 國家衛生研究院 |
2024-04 |
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
|
Tang, WF;Chang, YH;Lin, CC;Jheng, JR;Hsieh, CF;Chin, YF;Chang, TY;Lee, JC;Liang, PH;Lin, CY;Lin, GH;Cai, JY;Chen, YL;Chen, YS;Tsai, SK;Liu, PC;Yang, CM;Shadbahr, T;Tang, J;Hsu, YL;Huang, CH;Wang, LY;Chen, CC;Kau, JH;Hung, YJ;Lee, HY;Wang, WC;Tsai, HP;Horng, JT |
| 國家衛生研究院 |
2023-04-10 |
Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus
|
Chang, CC;Algaissi, A;Lai, CC;Chang, CK;Lin, JS;Wang, YS;Chang, BH;Chang, YC;Chen, WT;Fan, YQ;Peng, BH;Chao, CY;Tzeng, SR;Liang, PH;Sung, WC;Hu, AY;Chang, SC;Chang, MF |
| 中山醫學大學 |
2021 |
FUT8 Remodeling of EGFR Regulates Epidermal Keratinocyte Proliferation during Psoriasis Development
|
Kelel, M; Yang, RB; Tsai, TF; Liang, PH; Wu, FY; Huang, YT; Yang, MF; Hsiao, YP; Wang, LF; Tu, CF; Liu, FT; Lee, YLL |
| 中山醫學大學 |
2021 |
Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2
|
Kuo, CJ; Chao, TL; Kao, HC; Tsai, YM; Liu, YK; Wang, LHC; Hsieh, MC; Chang, SY; Liang, PH |
| 臺北醫學大學 |
2014 |
Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity
|
Jiang, PL;Lin, HJ;Wang, HW;Tsai, WY;Lin, SF;Chien, MY;Liang, PH;Huang, YY;Liu, DZ |
| 國家衛生研究院 |
2013-11 |
Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors
|
Lin, TS;Liw, YW;Song, JS;Hsieh, TC;Yeh, HW;Hsu, LC;Lin, CJ;Wu, SH;Liang, PH |
| 臺北醫學大學 |
2013 |
Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization
|
Wang, HW;Jiang, PL;Lin, SF;Lin, HJ;Ou, KL;Deng, WP;Lee, LW;Huang, YY;Liang, PH;Liu, DZ |
| 臺北醫學大學 |
2013 |
Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization
|
Wang, HW;Jiang, PL;Lin, SF;Lin, HJ;Ou, KL;Deng, WP;Lee, LW;Huang, YY;Liang, PH;Liu, DZ |
| 臺北醫學大學 |
2013 |
Targeting the XIAP/caspase-7 complex selectively kills caspase-3 deficient malignancies
|
Lin, YF;Lai, TC;Chang, CK;Chen, CL;Huang, MS;Yang, CJ;Liu, HG;Dong, JJ;Chou, YA;Hsiao, M;Liang, PH |
顯示項目 1-10 / 29 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
